Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01870726 |
| Title | Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Gliobastoma |
| Recruitment | Terminated |
| Gender | |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | NLD | ESP | DEU | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute SC | Boston | Massachusetts | 02215 | United States | Details | |
| Columbia University Medical Center- New York Presbyterian Dept of Oncology | New York | New York | 10032 | United States | Details | |
| Memorial Sloan Kettering Cancer Center Neurology | New York | New York | 90033 | United States | Details | |
| Duke University Medical Center Duke - Baker | Durham | North Carolina | 27710 | United States | Details | |
| University of Texas MD Anderson Cancer Center SC-3 | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | Bonn | 53105 | Germany | Details | ||
| Novartis Investigative Site | Heidelberg | 69120 | Germany | Details | ||
| Novartis Investigative Site | Tübingen | 72076 | Germany | Details | ||
| ErasmusMC Cancer Institute - Neurooncology, RM G3-55 | Rotterdam | 3075EA | Netherlands | Details | ||
| University Medical Center Utrecht, Rm Q05.4.300, P.O. Box 85500 | Utrecht | 3508 GA | Netherlands | Details | ||
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
| Novartis Investigative Site | Madrid | 28041 | Spain | Details | ||
| Novartis Investigative Site | St. Gallen | 9007 | Switzerland | Details |